Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727168 | SCV000237936 | likely benign | not provided | 2021-01-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727168 | SCV000706314 | uncertain significance | not provided | 2017-02-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001331658 | SCV001523749 | uncertain significance | Left ventricular noncompaction 2 | 2019-08-05 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001366707 | SCV001563020 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-24 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 34993 of the TTN protein (p.Thr34993Met). This variant is present in population databases (rs368945564, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 203088). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant is located in the M band of TTN (PMID: 25589632). Non-truncating variants in this region may be relevant for neuromuscular disorders, but have not been definitively shown to cause cardiomyopathy (PMID: 23975875). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000727168 | SCV003819785 | uncertain significance | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing |